Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Indivior Looks To Cement Addiction Drug Leadership With Opiant Buy
Paying $145m Upfront Plus CVR
Nov 14 2022
•
By
Kevin Grogan
Indivior Hopes Opiant Will Help It Tackle US Opioid Abuse Crisis • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business